Commercial Business Development Manager III

Donaldson is committed to solving the world’s most complex filtration challenges. Together, we make cool things. As an established technology and innovation leader, we are continuously evolving to meet the filtration needs of our changing world.

Join a culture of collaboration and innovation that matters and a chance to learn, effect change, and make meaningful contributions at work and in communities.

Isolere Bio, Inc. located in Research Triangle Park, NC, is one of Donaldson's latest addition to a growing list of biotechnology initiatives.

Isolere Bio develops reagents that combine engineered biopolymers with tunable phase separation, with affinity ligands that confer the unique material properties to the biologic target of interest.

The company offers a growing portfolio of purification solutions for a wide range of biologics, including AAV, lentivirus, mRNA, plasmid DNA and other viral particles.

This portfolio of IsoTag reagents are first of their kind and will catalyze a paradigm shift in bioprocessing. They offer significant competitive advantages improving productivity and quality while reducing the overall cost of goods for increasingly complex biologic drugs.

Combining Isolere’s deep expertise in liquid phase separation, and Donaldson’s filtration technology expertise, and global sales and manufacturing footprint, we are on a fast-track to develop and commercialize Isolere’s novel affinity liquid phase separation reagents for biologics purification.

The Commercial Business Development Manager III will play a crucial role in driving the growth and success of Isolere. Reporting to the GM of Isolere, the successful candidate will be responsible for identifying, developing, and executing strategic initiatives to expand our client base and increase revenue streams.

They will collaborate closely with internal teams to ensure alignment with organizational goals and objectives.

An ideal candidate will have experience within the life sciences industry launching and growing new technologies. This individual will be responsible for external-facing activities related to collaborations and partnerships, supply agreements, channel partnerships, and other business development transactions.

Due to the early nature of Isolere’s products, a great candidate will also have an entrepreneurial spirit while still being able to navigate the established supporting corporate culture of Donaldson and contribute to its growing life science business.

Role Responsibilities :

Develop and execute business deals that deliver value to Isolere and lead to early adopters (co-development and supply agreements)

Seek out and assess channel partnership opportunities

Develop and implement comprehensive business development strategies to achieve company objectives and targets.

Drive customer adoption and retention strategies

Seek out and nurture strong customer relationships with decision makers in customer segments, including pharma, biotech, C(D / M / R)Os, vector cores, and related industries

Develop and manage sales budgets, forecasts, and commercial team buildout

Regularly analyze sales cycle and adjust tactics accordingly

Develop processes and tools to ensure excellent customer experience and sales team operations

Support GM in compiling data and presentations for senior management

Support Isolere’s product and technology roadmaps by contributing information on customer needs and market trends

Participate in promotional activities including trade show attendance, as needed

Minimum Qualifications :

5+ years’ experience in life sciences corporate or business development role

Bachelor’s degree in Biology, Biosciences, Biochemical Engineering, Pharmaceutical Sciences, Biochemistry, or a related field.

Established network within the Pharma industry, especially advanced therapeutic modalities.

Preferred Qualifications :

Strong understanding of bioprocessing industry and its commercial drivers

Highly motivated individual with strong communication skills

Experience with adoption and commercialization of disruptive technologies and growing first $5M of revenue for a new business

Travel :

Must be willing to travel up to 40% primarily in the assigned regions (North America and EU)

Key words : commercial, sales, business development, pharmaceuticals, advanced therapies, life sciences

LI-Hybrid